Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

NCT00219583 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
460
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer